JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target
A rack of test tubes and beakers being stirred in a laboratory, as researchers analyze the data.
Janux Therapeutics, Inc. (NASDAQ:JANX) is expected to release additional data from its Phase 1 trials for JANX007 and JANX008 in H2 2025, which the analyst projects could affect its market position.
JANX007, a T cell-engaging antibody, is expected to be in competition with Pluvicto. Despite a complicated administration, Pluvicto already holds a considerable market share. However, the analyst reasoned that JANX007 could experience faster market adoption if it exhibits efficacy comparable to Pluvicto, which would positively impact Janux Therapeutics, Inc. (NASDAQ:JANX).
The analyst also noted that the safety profile of JANX007 would be critical, especially in regard to steroid use post-CRS resolution. Therefore, Roy reasoned that investor interest could grow with a favorable safety outcome.
Janux Therapeutics, Inc. (NASDAQ:JANX) is a preclinical stage biopharmaceutical company that develops therapeutics based on the Tumor Activated T Cell Engager platform technology. The company develops tumor-activated immunotherapies for cancer through two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr).
While we acknowledge the potential of JANX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
7 minutes ago
How major US stock indexes fared Friday, 8/15/2025
U.S. stocks edged back from their records, led by drops for technology companies, but Wall Street still closed out another winning week. The S&P 500 fell 0.3% Friday, slipping below the record it set a day earlier. The Dow Jones Industrial Average edged up 0.1%. The Nasdaq composite fell 0.4%. UnitedHealth Group jumped after Warren Buffett's Berkshire Hathaway said it bought nearly 5 million shares of the insurer in the spring, while Applied Materials slumped on worries about its business in China. Treasury yields rose following mixed reports on the U.S. economy. On Friday: The S&P 500 fell 18.74 points, or 0.3%, to 6,449.80. The Dow Jones Industrial Average rose 34.86 points, or 0.1%, to 44,946.12. The Nasdaq composite fell 87.69 points, or 0.4%, to 21,622.98. The Russell 2000 index of smaller companies fell 12.56 points, or 0.5%, to 2,686.52. For the week: The S&P 500 is up 60.35 points, or 0.9%. The Dow is up 770.51 points, or 1.7%. The Nasdaq is up 172.96 points, or 0.8%. The Russell 2000 is up 68.10 points, or 3.1%. For the year: The S&P 500 is up 568.17 points, or 9.7%. The Dow is up 2,401.90 points, or 5.6%. The Nasdaq is up 2,312.18 points, or 12%. The Russell 2000 is up 56.37 points, or 2.5%.
Yahoo
28 minutes ago
- Yahoo
High Yield and Low Stress: 2 Dividend ETFs That Are Built for Passive Income
Key Points Statistical evidence supports the idea that these two ETFs can simultaneously grow capital and generate income. Maximum monthly drawdowns are less than the benchmark's performance, and so is the risk as defined by standard deviation. These ETFs do relatively best when benchmark indexes are highly volatile but still make money in bull markets. 10 stocks we like better than JPMorgan Equity Premium Income ETF › The JPMorgan Equity Premium Income ETF (NYSEMKT: JEPI) and JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: JEPQ) have garnered significant investor attention, in part due to their trailing-12-month dividend yields of 8.2% and 11.2%, respectively. Moreover, they offer monthly income, making them a favorite among passive income investors. As such, it would be interesting to share some modeling of their performance to see if they do offer investors a way to a relatively low-volatility strategy that practically guarantees a monthly income. (Keep in mind dividends can always be cut.) Introducing two JPMorgan ETFs The first thing to understand about these two exchange-traded funds is that they are not tailored to invest in dividend stocks. Instead, they both follow the same strategy of investing up to 80% of net assets in equities (stocks), with the only difference being that the Equity Premium ETF focuses on S&P 500 stocks while the Nasdaq Equity Premium ETF focuses on stocks in the Nasdaq-100. As noted above, the stocks are not explicitly selected for their dividend yield, an essential point because high-yield equity-focused ETFs often involve concentrating holdings in sectors with high yields. The remaining net assets, up to 20%, are invested in equity-linked notes (ELNs) that follow a strategy of selling call options on the indexes that the two ETFs benchmark -- S&P 500 and Nasdaq-100, respectively. A call option is the right to buy shares of the index at a specified price (the strike price) and is bought by bullish investors. The seller of the call options (in this case the ETF) receives a premium from the buyer. However, if the index increases significantly, the option is exercised, and the ELN typically incurs a loss. Conversely, when the index experiences a small gain, stays flat, or loses value, the option isn't exercised. The idea is that an anticipated net profit in premiums collected from the ELNs, combined with some dividend income from stock holdings, will generate sufficient income for distributions to be paid to shareholders under any condition, particularly in the event of a substantial increase in the index. And note that the upside is limited (gains less than the market), but the downside is also restricted. This table lays out how the portions of the ETFs will perform based on how the underlying index performs in a month. Monthly Index Performance Strong Gain Moderate Gain Moderate Loss Strong Loss Equities (At least 80% of the ETF assets) Strong Gain Gain Loss Strong Loss ELNs (Up to 20% of the ETF's assets) Loss Profit Profit Profit Overall Gain, but less than the market Gain, but less than the market Slight profit/slight loss Loss, but less than the market Author's analysis. What the ETFs need to do to demonstrate they work Before I throw charts at you, it's worth noting that the proof of the strategy working includes: The ETF should have a lower volatility than the index (measured here by the standard deviation of monthly returns). The ETFs should have relatively low maximum monthly drawdowns because passive investors usually do not want to lose a significant amount in any one month. The strategy should demonstrate a high coefficient of determination, or R^2, indicating that the independent variable (in this case, the benchmark index) is primarily responsible for determining the outcome. Performance consistent with the outcomes outlined in the table above. That said, here are the charts comparing the monthly index performance to the ETF's performance. Both sets of data include reinvestment of dividends. First, here's the JPMorgan Equity Premium Income ETF. And now the JPMorgan Nasdaq Equity Premium Income ETF. A few conclusions can be drawn from the data, along with some additional calculations. The monthly standard deviation of the S&P 500 over the period is 4.7%, compared to 3.1% for JEPI, indicating lower volatility returns. The monthly standard deviation of the Nasdaq-100 over the period is 5.7%, compared to 4.2% for JEPQ, indicating lower volatility returns. Both ETFs exhibit high R^2 values, indicating a consistency of outcome from the strategy. The three most significant monthly drawdowns for JEPI are -6.4%, -4.2%, and -4.1%. The three most significant monthly drawdowns for JEPQ are -8.7%, -6.8%, and -6.6%. In general, the strategy is effective, generating a collection of positive returns when the indices report moderate gains and losses. The downside is limited compared to the index when the market declines significantly, and the upside is limited when the indexes perform well. What it means to passive investors Both indices have performed very well over the periods, with an average monthly gain of 1.5% on the S&P 500 and 1.8% on the Nasdaq; therefore, the ETFs have understandably underperformed. However, there's no guarantee that these conditions will continue, and these ETFs have demonstrated lower volatility returns while maintaining substantial dividends for those seeking monthly income. As such, they are excellent options for those seeking to generate passive income across a range of market conditions. Should you invest $1,000 in JPMorgan Equity Premium Income ETF right now? Before you buy stock in JPMorgan Equity Premium Income ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and JPMorgan Equity Premium Income ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 JPMorgan Chase is an advertising partner of Motley Fool Money. Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase. The Motley Fool has a disclosure policy. High Yield and Low Stress: 2 Dividend ETFs That Are Built for Passive Income was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
Could Buying $10,000 of Palantir Stock Still Make You a Millionaire?
Key Points Palantir stock has climbed more than 18-fold since its direct listing. The company is seeing accelerating revenue growth with expanding operating margins. There's a big hurdle standing in the way of continued increases in the stock price. 10 stocks we like better than Palantir Technologies › If you bought $10,000 of Palantir (NASDAQ: PLTR) stock in 2020 when shares first hit the public market, you'd have close to $187,000 as of this writing. That kind of money can create a solid foundation toward building a $1 million portfolio. Even if Palantir stock merely meets the average return of the S&P 500, keeping those shares for another 15 to 20 years could result in a shareholder reaching millionaire status. But a lot of people missed the boat on Palantir. The company's stock has zoomed higher since late 2022, as generative artificial intelligence (AI) has helped expand its capabilities and support profitable revenue growth. And if you're just looking to invest in Palantir shares today, you may be wondering if you missed the chance to become a millionaire on the back of a relatively small $10,000 investment in one of the hottest tech companies in the world. Looking into Palantir Palantir's software collects disparate data sets from an organization and external sources, cleans them, identifies connections, and provides valuable insights that aid decision-makers in their role. While cloud computing providers might offer their own analytics tools, Palantir's machine learning algorithms have proven extremely valuable, especially for customers with data spread across various sources. In 2023, Palantir launched its Artificial Intelligence Platform (AIP), which allows an organization to use a large language model to interact with its software using natural language. That has significantly lowered the technical expertise required to get the most out of Palantir while expanding its use cases. The financial results since that launch have been spectacular. Palantir just reported its eighth straight quarter of accelerating revenue growth, and management's outlook for the third quarter suggests a ninth is in the making. In that time, Palantir has become profitable, enjoying very strong operating leverage. Its adjusted operating margin climbed to 46% last quarter, up from 37% last year and 25% two years ago. CEO Alex Karp boasts that this kind of growth is unprecedented for a company with the scale of Palantir. The company surpassed $1 billion in revenue last quarter, and its so-called Rule of 40 score (revenue growth plus operating margin) came in at 94, blowing away the gold standard for investing in software companies. While the profitable revenue growth is extremely impressive, there's reason to doubt that Palantir's stock can continue to produce the same level of returns as it has over the last three years. It'll be hard for it to even come close. Can $10,000 invested today turn into $1 million? Turning $10,000 into $1 million requires an investment to increase 100-fold. To put that in perspective, Palantir currently has a market cap of $445 billion as of this writing. To increase 100-fold would put its market cap at $44.5 trillion. The largest company in the world right now has a market cap one-tenth that size. So, that's a big hurdle in and of itself. The more pressing issue, however, is the current valuation investors put on Palantir's stock. Shares currently trade for more than 100 times revenue expectations over the next 12 months. That's not just a high multiple, it's stratospheric. Other AI stocks can be had for multiples below 20-times sales. That said, few are growing like Palantir with its profitability and at its scale. Still, such a premium price is hard to justify. Even if Palantir grows revenue at an average rate of 50% through the end of 2030, its current price would still be about 14 times sales (five and a half years down the line). Only a handful of AI software stocks command a multiple like that for their 2026 revenue expectations. Palantir should see its price-to-sales multiple shrink over the next five years. Revenue won't accelerate forever, but many investors are acting like it should. Wall Street is decidedly bearish on the stock, but retail ownership (above 40%) continues to support the rising stock price. That makes Palantir extremely susceptible to an earnings miss or a shift in investor sentiment. Investors looking at the stock today may want to wait for a significant pullback in price before adding shares to their portfolio. It's unlikely that a $10,000 investment in Palantir today will make you a millionaire. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Adam Levy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. Could Buying $10,000 of Palantir Stock Still Make You a Millionaire? was originally published by The Motley Fool Sign in to access your portfolio
